Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Bevacizumab × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 58 Ovarian Neoplasms 33 Carcinoma, Hepatocellular 33 Neoplasms 22 Fallopian Tube Neoplasms 20 Carcinoma, Non-Small-Cell Lung 20 Colonic Neoplasms 13 Endometrial Neoplasms 12 Brain Neoplasms 11 Neoplasm Metastasis 10 Lung Neoplasms 10 Rectal Neoplasms 9 Glioblastoma 9 Liver Neoplasms 8 Breast Neoplasms 8 Uterine Cervical Neoplasms 7 Stomach Neoplasms 7 Carcinoma, Ovarian Epithelial 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Glioma 5 Carcinoma, Renal Cell 5 Small Cell Lung Carcinoma 4 Recurrence 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Biliary Tract Neoplasms 4 Advanced Solid Tumors 4 Neoplasms, Nerve Tissue 3 Meningeal Carcinomatosis 3 Melanoma 3

Interventions

Cyclophosphamide 5 Prednisone 4 Vincristine 3 Doxorubicin 3 Biopsy 3 Azacitidine 3 romidepsin 2 Gemcitabine 2 Dexamethasone 2 tazemetostat 1 sodium-iodide symporter 1 sintilimab 1 selinexor 1 ruxolitinib 1 relatlimab 1 pembrolizumab 1 ivarmacitinib 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cc-486 1 belinostat 1 X-Rays 1 Watchful Waiting 1 Spinal Puncture 1 Specimen Handling 1 Salvage Therapy 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡